COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,617 Articles (22,913 medRxiv, 8,704 bioRxiv)

Most recent first Previous |  Page 1338: Articles 13371-13380  | Next

Secreted SARS-CoV-2 ORF8 modulates the cytokine expression profile of human macrophages
Kriplani, N., Clohisey, S. M. R., Fonseca, S., Fletcher, S., Lee, H.-M., Ashworth, J., Kurian, D., Lycett, S. J., Tait-Burkard, C., Baillie, J. K., Woolhouse, M. E. J., Carding, S. R., Stewart, J. P., Digard, P.
10.1101/2021.08.13.456266 — Posted: 2021-08-13 Discussion: Onsite
Conserved T-cell epitopes predicted by bioinformatics in SARS-COV-2 variants
Lu, F., Wang, S., Wang, Y., Yao, Y., Wang, Y., Liu, S., Wang, Y., Yu, Y., Wang, L.
10.1101/2021.08.12.456182 — Posted: 2021-08-13
Covid-19 vaccine immunogenicity in people living with HIV-1
Nault, L., Marchitto, L., Goyette, G., Tremblay-Sher, D., Fortin, C., Martel-Laferriere, V., Trottier, B., Richard, J., Durand, M., Kaufmann, D. E., Finzi, A., Tremblay, C.
10.1101/2021.08.13.456258 — Posted: 2021-08-13
SARS-CoV-2 Neutralization in Commercial Lots of Plasma-derived Immunoglobulin
Volk, A., Covini-Souris, C., Kuehnel, D., de Mey, C., Roemisch, J., Schmidt, T.
10.1101/2021.08.13.456066 — Posted: 2021-08-13
SARS-CoV-2 spike opening dynamics and energetics reveal the individual roles of glycans and their collective impact
Pang, Y. T., Acharya, A., Lynch, D., Pavlova, A., Gumbart, J.
10.1101/2021.08.12.456168 — Posted: 2021-08-13
Another step toward final call on Remdesivir efficacy as a treatment for hospitalized COVID-19 patients: a multicenter open-label trial
Hosseini, H., Sadeghi, A., Tabarsi, P., Etemadimanesh, A., Alavi Darazam, I., Aghdami, N., Kalantari, S., Hasibi, M., Hadadi, A., Babamahmoodi, F., Momen-Heravi, M., Hormati, A., Panahi, Y., Khodashahi, R., Salehi, M.
10.1101/2021.08.13.21261992 — Posted: 2021-08-13
Altered increase in STAT1 expression and phosphorylation in severe COVID-19
Rincon-Arevalo, H., Aue, A., Ritter, J., Szelinski, F., Khadzhynov, D., Zickler, D., Stefanski, A.-L., Lino, A. C., Koerper, S., Eckardt, K.-U., Schrezenmeier, H., Doerner, T., Schrezenmeier, E.
10.1101/2021.08.13.21262006 — Posted: 2021-08-13
Healthcare presentations with self-harm and the association with COVID-19: an e-cohort whole-population-based study using individual-level linked routine electronic health records in Wales, UK, 2016 - March 2021
del Pozo Banos, M., Lee, S. C., Friedmann, Y., Akbari, A., Tobari, F., Lloyd, K. R., Lyons, R. A., John, A.
10.1101/2021.08.13.21261861 — Posted: 2021-08-13
THE EFFECT OF BARICITANIB USAGE ON THE CLINICAL AND BIOCHEMICAL PROFILES OF COVID-19 PATIENTS- A RETROSPECTIVE OBSERVATIONAL STUDY
Amarnath, A., Das, A., Mutya, V. S. S., Ibrahim, I.
10.1101/2021.08.11.21261760 — Posted: 2021-08-13
How did people cope during the COVID-19 pandemic? A Structural Topic Modelling Analysis of Free-Text Data from 11,000 UK Adults
Wright, L., Fluharty, M. E., Steptoe, A., Fancourt, D.
10.1101/2021.08.13.21262002 — Posted: 2021-08-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).